ARMC10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.991600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.622200E-01
Normal-vs-Stage2
3.160400E-01
Normal-vs-Stage3
7.855400E-01
Normal-vs-Stage4
9.088200E-02
Stage1-vs-Stage2
1.777840E-01
Stage1-vs-Stage3
6.688400E-01
Stage1-vs-Stage4
2.654200E-02
Stage2-vs-Stage3
1.074560E-01
Stage2-vs-Stage4
1.519950E-01
Stage3-vs-Stage4
7.258000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.388800E-01
Normal-vs-AfricanAmerican
7.516200E-02
Normal-vs-Asian
5.400000E-01
Caucasian-vs-AfricanAmerican
1.432100E-02
Caucasian-vs-Asian
7.793200E-01
AfricanAmerican-vs-Asian
3.410000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.640600E-01
Normal-vs-Female
4.575800E-01
Male-vs-Female
4.891200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.972000E-01
Normal-vs-Age(41-60Yrs)
2.264200E-01
Normal-vs-Age(61-80Yrs)
5.274000E-01
Normal-vs-Age(81-100Yrs)
3.561800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.290020E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.092000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.360000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.683100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.289800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.451400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.827600E-01
Normal-vs-Daily Drinker
5.527000E-01
Normal-vs-Weekly Drinker
3.409000E-01
Normal-vs-Occasional Drinker
3.444200E-01
Normal-vs-Social Drinker
2.036400E-01
Non Drinker-vs-Daily Drinker
9.331400E-01
Non Drinker-vs-Weekly Drinker
8.890000E-01
Non Drinker-vs-Occasional Drinker
8.838000E-01
Non Drinker-vs-Social Drinker
4.368000E-01
Daily Drinker-vs-Weekly Drinker
8.285400E-01
Daily Drinker-vs-Occasional Drinker
8.120200E-01
Daily Drinker-vs-Social Drinker
3.473600E-01
Weekly Drinker-vs-Occasional Drinker
9.978000E-01
Weekly Drinker-vs-Social Drinker
4.090600E-01
Occasional Drinker-vs-Social Drinker
3.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.558040E-01
Normal-vs-Grade 2
2.639700E-03
Normal-vs-Grade 3
1.741680E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.91359999996066E-06
Grade 1-vs-Grade 3
1.816250E-04
Grade 1-vs-Grade 4
1.558040E-01
Grade 2-vs-Grade 3
5.280400E-01
Grade 2-vs-Grade 4
2.639700E-03
Grade 3-vs-Grade 4
1.741680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.951200E-01
Normal-vs-NonDiabetic
3.758000E-01
Diabetic-vs-NonDiabetic
3.508000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.584610E-01
Normal-vs-NoPancreatitis
4.633800E-01
Pancreatitis-vs-NoPancreatitis
2.100800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.194200E-01
Normal-vs-N1
3.556400E-01
N0-vs-N1
2.183600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.342200E-02
Normal-vs-TP53-NonMutant
6.541800E-01
TP53-Mutant-vs-TP53-NonMutant
3.74880000000299E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
